Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Gentle scar massage could ease Long-Term breast pain after cancer treatment

NCT ID NCT07206394

Symptom relief Sponsor: University College London Hospitals Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This small study tests whether ScarWork, a gentle hands-on massage technique, can help women who have ongoing breast pain after surgery and radiotherapy for early-stage breast cancer. Forty participants will be randomly assigned to receive up to five ScarWork sessions plus usual care, or usual care alone. The goal is to see if the therapy is practical in an NHS setting and worth testing in a larger trial.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
ScarWork manual therapy (gentle massage of scar tissue)
What this could lead to
If it works, this could point toward a simple, non-drug option to ease persistent breast pain after cancer surgery.
What could go wrong
This is a very small early feasibility study with only 40 people. It is not designed to prove effectiveness, only to see if a larger trial is possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 40 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2025

Expected to finish

Jun 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Over the age of 18 * Early breast cancer patients who have had breast surgery with curative intent * Radiotherapy completed ≥ 6 months previously * In remission with no sign of active local disease * Registering a score of ≥3 on perceived pain intensity or pain burden on a 10-point numerical rating scale (NRS) * English speaking and able to communicate reasonably well * Able to give informed consent * Willing to attend for regular treatment at RLHIM Exclusion Criteria: * History of post-breast surgery wound complications * History of breast surgery unrelated to breast cancer treatment * History of previous ScarWork therapy * Diagnosis of lymphoedema * Severe co-morbidities or cognitive disability * Receiving physiotherapy for post-breast surgery pain syndrome at the time of trial

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Breast cancer early stage breast cancer (stage 1-3) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Breast cancer early stage breast cancer (stage 1-3)

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Royal London Hospital for Integrated Medicine

    RECRUITING

    London, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.